These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 24921216)

  • 1. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
    Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
    Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells.
    Kong D; Ma S; Liang B; Yi H; Zhao Y; Xin R; Cui L; Jia L; Liu X; Liu X
    Biomed Pharmacother; 2012 Jun; 66(4):271-8. PubMed ID: 22564245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
    Yin Q; Shen J; Zhang Z; Yu H; Li Y
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro.
    Yang S; Liu J; Chen Y; Jiang J
    Biomed Pharmacother; 2012 Apr; 66(3):187-94. PubMed ID: 22440896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming multidrug resistance with nanomedicines.
    Ganoth A; Merimi KC; Peer D
    Expert Opin Drug Deliv; 2015 Feb; 12(2):223-38. PubMed ID: 25224685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.
    Teo KY; Han B
    J Biomech Eng; 2009 Jul; 131(7):074513. PubMed ID: 19640149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edelfosine lipid nanoparticles overcome multidrug resistance in K-562 leukemia cells by a caspase-independent mechanism.
    Aznar MÁ; Lasa-Saracíbar B; Blanco-Prieto MJ
    Mol Pharm; 2014 Aug; 11(8):2650-8. PubMed ID: 24865362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol.
    Ahn JH; Jang GH; Lee M
    J Cell Physiol; 2013 Jul; 228(7):1496-505. PubMed ID: 23254564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q; Yang Z; Nie Y; Shi Y; Fan D
    Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.